Drug intelligence / Profile preview

Keming Capsule

Development stage
Unknown
Lead developer
Jinan Kangzhong Pharmaceutical Technology Development
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Keming Capsule is a Traditional Chinese Medicine (TCM) developed by Jinan Kangzhong Pharmaceutical Technology Development for the treatment of post-infectious cough (PIC). It is specifically formulated for patients exhibiting the TCM pattern of "yang deficiency and cold invading lung" (阳虚寒袭肺证). The therapeutic rationale involves warming the lungs and dispersing cold to alleviate persistent coughing following a respiratory infection. As of 2024, the drug is in Phase III clinical development in China, evaluated in a multicenter, randomized, double-blind, placebo-controlled trial (CTR20240031) to assess its efficacy and safety, with the primary endpoint being the cough resolution rate measured by the Visual Analogue Scale (VAS).

Brand names
Keming Capsule
Other names
克明胶囊Keming Jiaonang
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)STAT3 (Signal Transducer and Activator of Transcription 3)RELA (Nuclear Factor Kappa B Subunit p65)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Keming Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keming Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call